A-B) HT-29 cells were treated for 30 hours, then ChIP assay was performed to look for menin (A), RNA polymerase II, H3K4me3, and total H3 (B) at amplicon 1 of the SKP2 promoter. 10 μM gefitinib, 1 μM MI-2–2. *p < 0.05 compared to Control. C-D) HT-29 cells were treated for 30 hours, then ChIP assay was performed to look for menin (C) and RNA polymerase II (D) at amplicon 1 of the SKP2 promoter. 10 μM gefitinib, 1 μM MI-2–2, 2 μM BAPTA-AM. *p < 0.05 compared to Control and BAPTA-AM. E) Chelex resin eluent after incubation with HT-29 cell lysate. Uncharged resin or resin prepared with NaOH or CaCl2. Equal volumes of eluent were utilized to analyze protein by western blot. Ponceau S demonstrated no significant non-specific protein binding to resin. F) Chelex resin eluent after incubation with purified recombinant menin protein. Uncharged resin or resin prepared with NaOH or CaCl2. Equal volumes of eluent were utilized to analyze protein by western blot. G) After incubation with recombinant menin protein, uncharged and CaCl2 Chelex resin was washed with different calcium concentrations with resulting protein eluent examined by western blot. H-I) Differential scanning fluorimetry was performed on purified recombinant menin protein with different concentrations of CaCl2, with example fitted curves (H) and average melting temperatures (I).